Ganesh Rajendra Kokil
Ganesh Rajendra Kokil
School of Pharmacy, The University of Queensland, Australia
Verified email at uq.edu.au
Title
Cited by
Cited by
Year
Novel chromeneimidazole derivatives as antifungal compounds: synthesis and in vitro evaluation
S Thareja, A Verma, A Kalra, S Gosain, PV Rewatkar, GR Kokil
Acta Pol Pharm 67, 423-427, 2010
672010
Synthesis and in vitro evaluation of novel 1, 2, 4-triazole derivatives as antifungal agents
GR Kokil, PV Rewatkar, S Gosain, S Aggarwal, A Verma, A Kalra, ...
Letters in Drug Design & Discovery 7 (1), 46-49, 2010
502010
Type 2 diabetes mellitus: limitations of conventional therapies and intervention with nucleic acid-based therapeutics
GR Kokil, RN Veedu, GA Ramm, JB Prins, HS Parekh
Chemical Reviews 115 (11), 4719-4743, 2015
482015
Pharmacology and chemistry of diabetes mellitus and antidiabetic drugs: A critical review
G R Kokil, P V Rewatkar, A Verma, S Thareja, S R Naik
Current medicinal chemistry 17 (35), 4405-4423, 2010
422010
Bioprecursor Prodrugs: Molecular Modification of the Active Principle
G R Kokil, P V Rewatkar
Mini Reviews in Medicinal Chemistry 10 (14), 1316-1330, 2010
222010
Sulphonamides as inhibitors of protein tyrosine phosphatase 1B: A three-dimensional quantitative structure–activity relationship study using self-organizing molecular field …
S Thareja, GR Kokil, S Aggarwal, TR Bhardwaj, M Kumar
Chemical and Pharmaceutical Bulletin 58 (4), 526-532, 2010
182010
Skin delivery of EGCG and silibinin: potential of peptide dendrimers for enhanced skin permeation and deposition
PK Shetty, J Manikkath, K Tupally, G Kokil, AR Hegde, SY Raut, ...
AAPS PharmSciTech 18 (6), 2346-2357, 2017
172017
Rheumatoid arthritis: a new challenge in coming era.
PV Rewatkar, GR Kokil, A Verma, S Thareja
Mini reviews in medicinal chemistry 10 (2), 98-107, 2010
162010
Chapter 12 – Development and Discovery Avenues in Bioactive Natural Products for Glycemic Novel Therapeutics
SR Naik, GR Kokil
Studies in Natural Products Chemistry 39, 431-466, 2013
102013
Oseltamivir: A First Line Defense Against Swine Flu
R Agrawal, P V Rewatkar, G R Kokil, A Verma, A Kalra
Medicinal Chemistry 6 (4), 247-251, 2010
82010
Self-assembling asymmetric peptide-dendrimer micelles–a platform for effective and versatile in vitro nucleic acid delivery
GR Kokil, RN Veedu, BT Le, GA Ramm, HS Parekh
Scientific reports 8 (1), 1-16, 2018
62018
QSAR studies of phthalazinones: novel inhibitors of poly (ADP-ribose) polymerase
PV Rewatkar, GR Kokil, MK Raut
Medicinal Chemistry Research 20 (7), 877-886, 2011
52011
Development of a hybrid peptide dendrimer micellar carrier system and its application in the reformulation of a hydrophobic therapeutic agent derived from traditional Chinese …
J Jing, KR Tupally, GR Kokil, Z Qu, S Chen, HS Parekh
RSC advances 9 (5), 2458-2463, 2019
32019
Direct and indirect drug design approaches for the development of novel tricyclic antipsychotics: Potential 5-HT2A antagonist
MN Jadhav, GR Kokil, SS Harak, SB Wagh
Journal of Chemistry 2013, 2013
32013
Microencapsulated islet-like microtissues with toroid geometry for enhanced cellular viability
Y Chen, DT Nguyen, GR Kokil, YX Wong, TT Dang
Acta biomaterialia 97, 260-271, 2019
2019
Concentration stability of monolayer and bilayer lipid microbubbles–a precursor for new drug delivery applications
H Alsadiq, KR Tupally, GR Kokil, R Vogel, HS Parekh, M Veidt
2019
Development and delivery of novel modified siRNA-based therapeutics against type 2 diabetes
G Kokil
2016
Introduction to Diabetes and Type 1 Diabetes
P Singh, GR Kokil, KR Tupally, K Poddar, A Tan, V Venkatesan, ...
Therapeutic Perspectives in Type-1 Diabetes, 1-6, 2016
2016
Therapeutic Perspectives in Type-1 Diabetes
P Singh, RK GANESH, RT KARNAKER, K Poddar, A Tan, V Venkatesan, ...
Springer, 2016
2016
Predictors and Pathogenesis of Type 1 Diabetes
P Singh, GR Kokil, KR Tupally, K Poddar, A Tan, V Venkatesan, ...
Therapeutic Perspectives in Type-1 Diabetes, 21-28, 2016
2016
The system can't perform the operation now. Try again later.
Articles 1–20